Package of care for advanced HIV disease: policy brief
World Health Organization.
Geneva; World Health Organization; 2018. (WHO/CDS/HIV/18.3).
em Inglês | WHOLIS | ID: who-260446
Documentos relacionados
Clinical characteristics, treatment, and outcome of low-risk non-HIV-associated cryptococcal meningitis: A retrospective cohort study.
Fatal cryptococcal meningitis in the Non-HIV infected: A case report.
The prognostic factors for cryptococcal meningitis in non-human immunodeficiency virus patients: An observational study using nationwide database.
Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease.
The effect of serum uric acid, bilirubin, and albumin levels on antioxidant status in HIV-negative immunocompetent cryptococcal meningitis patients with post-infectious inflammatory response syndrome.
Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal Meningitis.
Diagnosis and management of cryptococcal meningitis in HIV-infected adults.
Association of semi-quantitative cryptococcal antigen results in plasma with subclinical cryptococcal meningitis and mortality among patients with advanced HIV disease.
Cryptococcal meningitis in people living with human immunodeficiency virus in Nepal: Perspectives from resource limited setting.
Development and validation of a machine learning model to predict prognosis in HIV-negative cryptococcal meningitis patients: a multicenter study.